Optimising General Practice Long COVID Care - an Educational Intervention.

ConditionLong COVID
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity College Dublin

About this trial

This trial will evaluate the feasibility of a pilot educational intervention for GPs that aims to enhance care and care outcomes among patients with long COVID at six general practices in the Ireland East region.

Our first objective is to conduct focus groups with key stakeholders (GPs, other health professionals, patients, families/carers) that will inform the contents of an education intervention. The second objective will be to implement this educational intervention, and the third objective will be to determine whether the intervention is feasible.

Study outcomes will include:

* Qualitative findings from co-design focus groups and post-intervention semi-structured interviews with GPs. * Practice and patient study recruitment and retention data. * GP / Practice characteristics: age \& gender, practice location, general and COVID-19 patient population figures. * Patient characteristics: Patient age, gender, COVID-19 vaccination status, and medical history details. * Patient scores on a self-report measure assessing the symptoms, symptom severity, functional impact, and overall health (COVID-19 Yorkshire Rehabilitation Scale (C-19-YRS)).

Eligibility criteria

Qualifiers

Age: Aged 18 years or older at the time of enrolment.

Registration: Are registered as patients at the study's participating practices.

Previously received a positive COVID-19 PCR or antigen test, or

Previously been clinically diagnosed with COVID-19 by a healthcare provider.

Disqualifiers

People with language difficulties that prevent meaningful communication.

Individuals with a recognised or diagnosed intellectual, physical, or mental impairment.

Older adults considered particularly vulnerable.

Individuals residing in institutions (e.g., care homes or prisons).

Trial design

Treatments tested in this trial

  • Intervention Group

Treatment groups

72 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University College Dublin

Lead sponsor

HRB Primary Care Clinical Trials Network Ireland

Collaborator

Mater Misericordiae University Hospital

Collaborator

Irish College of General Practitioners

Collaborator

St Vincent's University Hospital, Ireland

Collaborator

Health Services Executive, Ireland

Collaborator

South East Technological University, Ireland

Collaborator

National Rehabilitation Hospital, Dublin, Ireland (NRH)

Collaborator